Cargando…
Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is usually diagnosed in an advanced stage and has become the second deadliest type of cancer worldwide. The systemic treatment of advanced HCC has been a challenge, and for decades was limited to treatment with tyrosine kinase inhibitors (TKIs) until the application of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226303/ https://www.ncbi.nlm.nih.gov/pubmed/35757756 http://dx.doi.org/10.3389/fimmu.2022.896752 |